LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | A443654 | 0.04 | uM | LJP6 | 72 | hr | 962 | 10928 | 10605 | 1.0305 | 1.0336 |
MCF 10A | OSI-027 | 0.04 | uM | LJP6 | 72 | hr | 962 | 7454 | 10605 | 0.7029 | 0.6733 |
MCF 10A | XMD11-85h | 0.04 | uM | LJP6 | 72 | hr | 962 | 10945 | 10605 | 1.0321 | 1.0353 |
MCF 10A | HG-6-64-01 | 0.04 | uM | LJP6 | 72 | hr | 962 | 10078 | 10605 | 0.9503 | 0.9453 |
MCF 10A | WH-4-025 | 0.04 | uM | LJP5 | 72 | hr | 962 | 9950 | 10605 | 0.9382 | 0.9321 |
MCF 10A | WZ-4-145 | 0.04 | uM | LJP6 | 72 | hr | 962 | 10423 | 10605 | 0.9829 | 0.9812 |
MCF 10A | XMD16-144 | 0.04 | uM | LJP5 | 72 | hr | 962 | 2697 | 10605 | 0.2543 | 0.1799 |
MCF 10A | Brivanib | 0.04 | uM | LJP5 | 72 | hr | 962 | 10548 | 10605 | 0.9947 | 0.9941 |
MCF 10A | Buparlisib | 0.04 | uM | LJP5 | 72 | hr | 962 | 10708 | 10605 | 1.0097 | 1.0107 |
MCF 10A | BX-912 | 0.04 | uM | LJP5 | 72 | hr | 962 | 9662 | 10605 | 0.9111 | 0.9022 |
MCF 10A | Canertinib | 0.04 | uM | LJP6 | 72 | hr | 962 | 7868 | 10605 | 0.7419 | 0.7162 |
MCF 10A | Celastrol | 0.04 | uM | LJP6 | 72 | hr | 962 | 11411 | 10605 | 1.0760 | 1.0836 |
MCF 10A | CGP60474 | 0.04 | uM | LJP5 | 72 | hr | 962 | 4799 | 10605 | 0.4526 | 0.3979 |
MCF 10A | CGP60474 | 0.04 | uM | LJP6 | 72 | hr | 962 | 400 | 10605 | 0.0378 | -0.0582 |
MCF 10A | CHIR-99021 | 0.04 | uM | LJP6 | 72 | hr | 962 | 11451 | 10605 | 1.0798 | 1.0878 |
MCF 10A | CP724714 | 0.04 | uM | LJP5 | 72 | hr | 962 | 10777 | 10605 | 1.0162 | 1.0178 |
MCF 10A | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 962 | 10626 | 10605 | 1.0020 | 1.0022 |
MCF 10A | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 10700 | 10605 | 1.0090 | 1.0099 |
MCF 10A | Momelotinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 10172 | 10605 | 0.9592 | 0.9551 |
MCF 10A | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 8953 | 10605 | 0.8442 | 0.8287 |
MCF 10A | Dasatinib | 0.04 | uM | LJP6 | 72 | hr | 962 | 2885 | 10605 | 0.2721 | 0.1995 |
MCF 10A | Dovitinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 10483 | 10605 | 0.9886 | 0.9874 |
MCF 10A | Enzastaurin | 0.04 | uM | LJP5 | 72 | hr | 962 | 10758 | 10605 | 1.0144 | 1.0159 |
MCF 10A | Erlotinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 9767 | 10605 | 0.9210 | 0.9131 |
MCF 10A | Foretinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 10370 | 10605 | 0.9779 | 0.9757 |